Roche enters weight loss and metabolic market with Carmot Therapeutics acquisitionRoche has completed its acquisition of Carmot Therapeutics, which includes Carmot’s R&D portfolio including all clinical and pre-clinical...
Roche poised to enter anti-obesity medication market with agreement to acquire Carmot TherapeuticsRoche is poised to enter the lucrative anti-obesity medication market after entering into a definitive merger agreement to acquire Carmot...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment3 days ago